Skip to content
Home/Companies/Biotech/Diatech
DI

Diatech

Biotech·Italy·Exited 2023·Held 2yr

Diatech is a biotech company, headquartered in Italy.

Entry
2021
Hold
2yr
Exit
2023
Est. EV
–

Who owns Diatech?

Diatech was owned by Alto Partners SGR through Alto Capital IV (2017 vintage) from 2021 to 2023, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-19

Alto Partners SGR
Investor
Alto Partners SGR
Alto Capital IV · 2017 · Small-Mid Buyout

Key facts

HQItaly
SectorBiotech
StatusAcquired
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2023

More from Alto Capital IV

Other portfolio companies in the same fund.

CEI (reinvestment)
Active
IndustrialsItaly· 2022
DMX Pharma
Exited 2025
PharmaItaly· 2022
to
CEI
Exited 2022
IndustrialsItaly· 2020
to
Bia
Exited 2022
ConsumerItaly· 2019
to
OFI
Exited 2020
PharmaItaly· 2019
to
Olimpia Splendid
Exited 2025
IndustrialsItaly· 2019
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Adcendo
Active
Jeito CapitalDenmark· 2026
Data refreshed weekly · Sourced from public filings